Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)

NCT06292585 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT06292585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 2, 2024
Completion date
December 31, 2026
Enrollment
194 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidural hematoma, traumatic brain injury